Bacterial signal transduction systems are responsible for sensing environmental cues and adjusting the cellular behaviour and/or metabolism in response to these cues. They also monitor the intracellular conditions and the status of the cell envelope and the cytoplasmic membrane and trigger various stress responses to counteract adverse changes. This surveillance involves several classes of sensor proteins: histidine kinases; chemoreceptors; membrane components of the sugar phosphotransferase system; adenylate, diadenylate and diguanylate cyclases and certain cAMP, c-di-AMP and c-di-GMP phosphodiesterases; extracytoplasmic function sigma factors and Ser/Thr/Tyr protein kinases and phosphoprotein phosphatases. We have compiled a detailed listing of sensor proteins that are encoded in the genomes of Escherichia coli, Bacillus subtilis and 10 widespread pathogens: Chlamydia trachomatis, Haemophilus influenzae, Helicobacter pylori, Mycobacterium tuberculosis, Mycoplasma pneumoniae, Neisseria gonorrhoeae, Porphyromonas gingivalis, Rickettsia typhi, Streptococcus pyogenes and Treponema pallidum, and checked what, if anything, is known about their functions. This listing shows significant gaps in the understanding of which environmental and intracellular cues are perceived by these bacteria and which cellular responses are triggered by the changes in the respective parameters. A better understanding of bacterial preferences may suggest new ways to modulate the expression of virulence factors and therefore decrease the reliance on antibiotics to fight infection.
Keyphrases
- biofilm formation
- helicobacter pylori
- escherichia coli
- bacillus subtilis
- pseudomonas aeruginosa
- mycobacterium tuberculosis
- staphylococcus aureus
- candida albicans
- binding protein
- helicobacter pylori infection
- poor prognosis
- protein kinase
- public health
- single cell
- human health
- social support
- reactive oxygen species
- life cycle
- depressive symptoms
- gram negative
- cell therapy
- antimicrobial resistance
- physical activity
- cystic fibrosis
- risk assessment
- multidrug resistant
- stem cells
- amino acid
- mesenchymal stem cells
- bone marrow